-
Signature
-
/s/ Joshua Patterson, Attorney-in-Fact for Christina Rossi
-
Issuer symbol
-
CGON
-
Transactions as of
-
24 Nov 2025
-
Net transactions value
-
$0
-
Form type
-
4
-
Filing time
-
26 Nov 2025, 16:30:09 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Rossi Christina |
Director |
C/O CG ONCOLOGY, INC., 400 SPECTRUM CENTER DRIVE, SUITE 2040, IRVINE |
/s/ Joshua Patterson, Attorney-in-Fact for Christina Rossi |
26 Nov 2025 |
0001756941 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CGON |
Director Stock Option (right to buy) |
Award |
$0 |
+20,889 |
|
$0.000000 |
20,889 |
24 Nov 2025 |
Common Stock |
20,889 |
$43.56 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: